Characterizing inflammatory markers in highly aggressive soft tissue sarcomas
Open Access
- 30 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (39) , e30688
Abstract
The prognosis for soft tissue sarcomas (STSs) is poor, especially for highly aggressive STSs, and the details of prognostic factors are unknown. This study aimed to investigate the prognostic factors for STSs in hematologic inflammatory markers. We included 22 patients with STSs treated at our institution. The STSs were histologically classified as follows: undifferentiated pleomorphic sarcoma, 7 cases; myxofibrosarcoma, 6 cases; and malignant peripheral nerve sheath tumor, 2 cases. The average patient age was 72.06 years. The numbers of patients who underwent each procedure were as follows: wide resection, 7; wide resection and flap, 2; marginal resection, 2; wide resection and radiation, 1; additional wide resection with flap, 1; wide resection and skin graft, 1; and radiotherapy only, 1. The median follow-up period was 26 months (3–92 months). The outcomes were as follows: continuous disease free, 6 cases; no evidence of disease, 6 cases; alive with disease, 1 case; and died of disease, 2 cases. Pretreatment blood examinations for C-reactive protein (CRP) and albumin levels; neutrophil, lymphocyte, and white blood cell (WBC) counts; and neutrophil/lymphocyte (N/L) ratio were investigated and correlated with tumor size, tissue grade, and maximum standardized uptake value (SUVmax). CRP level and neutrophil and WBC counts were positively correlated with tissue grade and SUVmax. N/L ratio was positively correlated with tumor size and SUVmax. CRP level, WBC and neutrophil counts, and N/L ratio may be poor prognostic factors for highly aggressive STSs.Keywords
This publication has 31 references indexed in Scilit:
- Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisCancer Epidemiology, Biomarkers & Prevention, 2014
- Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parametersSkeletal Radiology, 2014
- The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomasInternational Journal of Cancer, 2013
- The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcomaJournal of Surgical Oncology, 2013
- Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinomaBMC Cancer, 2013
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet, 2012
- The symptom interval in children and adolescents with soft tissue sarcomasCancer, 2009
- Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly PatientsAnnals of Surgical Oncology, 2009
- The correlation coefficient: Its values range between +1/−1, or do they?Journal of Targeting, Measurement and Analysis for Marketing, 2009
- Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemInternational Journal of Cancer, 1984